Company Filing History:
1 out of 512 
1 out of 832,761 Years Active: 1987-1989
Title: Ryuzo Ueda: Innovator in Monoclonal Antibody Research
Introduction
Ryuzo Ueda is a prominent inventor based in Nagoya, Japan. He has made significant contributions to the field of biomedical research, particularly in the development of monoclonal antibodies. His work has implications for cancer research and treatment, showcasing his dedication to advancing medical science.
Latest Patents
Ryuzo Ueda holds 2 patents that focus on monoclonal antibodies. His latest patents include:
1. Monoclonal antibodies to human leukocyte antigens.
2. Monoclonal antibodies to cell surface antigens of human renal cancer.
These patents describe the preparation and use of monoclonal antibodies that bind to glycoproteins of 160Kd, 120Kd, and 115Kd, as well as a glycolipid, a HLA heavy chain, and group A and B blood antigens.
Career Highlights
Throughout his career, Ueda has worked at the Sloan-Kettering Institute for Cancer Research. His research has been pivotal in understanding the mechanisms of cancer and developing targeted therapies.
Collaborations
Ueda has collaborated with notable colleagues, including Lloyd J. Old and Kenneth O. Lloyd. Their combined expertise has contributed to advancements in cancer research and treatment methodologies.
Conclusion
Ryuzo Ueda's innovative work in monoclonal antibody research has made a lasting impact on the field of cancer treatment. His patents and collaborations reflect his commitment to improving medical outcomes for patients.